70631-71-9 Usage
Aromatic hydrocarbon compound
1-Fluoro-6-methylnaphthalene is a compound that contains a naphthalene ring, which is a fused system of two benzene rings.
Fluorine atom
1-Fluoro-6-methylnaphthalene contains a fluorine atom that is attached to the naphthalene ring, which gives the compound unique chemical properties.
Methyl group
The compound also contains a methyl group (a carbon atom bonded to three hydrogen atoms) that is attached to the naphthalene ring, which can affect its reactivity and physical properties.
Precursor in organic synthesis
1-Fluoro-6-methylnaphthalene is commonly used as a starting material or precursor in the synthesis of various organic compounds and pharmaceutical products.
Building block in polymer production
The compound is also used as a building block in the production of polymers, which are large molecules made up of repeating units.
Use in dye and pesticide production
1-Fluoro-6-methylnaphthalene is used in the production of dyes and pesticides, which are chemicals that are used to control pests and improve the appearance of products.
Potential toxicity
1-Fluoro-6-methylnaphthalene has some potential toxicity, and it should be handled with care in a laboratory setting to avoid adverse effects on human health and the environment.
Safety precautions
It is important to follow proper safety precautions when working with 1-Fluoro-6-methylnaphthalene, such as wearing appropriate personal protective equipment and handling the chemical in a well-ventilated area.
Check Digit Verification of cas no
The CAS Registry Mumber 70631-71-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,0,6,3 and 1 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 70631-71:
(7*7)+(6*0)+(5*6)+(4*3)+(3*1)+(2*7)+(1*1)=109
109 % 10 = 9
So 70631-71-9 is a valid CAS Registry Number.
70631-71-9Relevant articles and documents
DIHYDROIMIDAZOTHIAZOLE DERIVATIVES
-
Page/Page column 66, (2008/06/13)
Compounds of formula (I): or pharmaceutically acceptable salts thereof, exhibit 5-HT1A agonism in addition to noradrenaline reuptake inhibition and optionally also 5-HT reuptake inhibition are useful for the treatment of obesity.
